Parallax Volatility Advisers
ARKG icon

Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Parallax Volatility Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$735K Sell
17,482
-1,589
-8% -$50.6K ﹤0.01% 1037
2026
Q1 		$586K Sell
19,071
-1,998
-9% -$58.5K ﹤0.01% 1035
2025
Q4 		$610K Sell
21,069
-2,184
-9% -$65.6K ﹤0.01% 1195
2025
Q3 		$646K Sell
23,253
-12,498
-35% -$316K ﹤0.01% 1205
2025
Q2 		$871K Sell
35,751
-72,544
-67% -$1.59M ﹤0.01% 1089
2025
Q1 		$2.25M Buy
108,295
+75,045
+226% +$1.89M 0.01% 840
2024
Q4 		$783K Buy
33,250
+24,589
+284% +$605K ﹤0.01% 1399
2024
Q3 		$222K Sell
8,661
-105
-1% -$2.67K ﹤0.01% 1675
2024
Q2 		$206K Sell
8,766
-23,661
-73% -$597K ﹤0.01% 1603
2024
Q1 		$933K Buy
32,427
+10,505
+48% +$316K ﹤0.01% 1258
2023
Q4 		$719K Sell
21,922
-8,057
-27% -$219K ﹤0.01% 1508
2023
Q3 		$835K Buy
29,979
+7,785
+35% +$255K ﹤0.01% 1431
2023
Q2 		$757K Sell
22,194
-4,017
-15% -$126K ﹤0.01% 1510
2023
Q1 		$788K Buy
26,211
+26,210
+2,621,000% +$812K ﹤0.01% 1595
2022
Q4 		$28 Hold
1
– – ﹤0.01% 2816
2022
Q3 		$0 Sell
1
-170,565
-100% -$6.26M ﹤0.01% 3046
2022
Q2 		$5.37M Buy
170,566
+109,079
+177% +$3.81M 0.01% 951
2022
Q1 		$2.82M Sell
61,487
-21,327
-26% -$1.02M ﹤0.01% 1227
2021
Q4 		$5.07M Buy
82,814
+33,717
+69% +$2.33M ﹤0.01% 1192
2021
Q3 		$3.67M Buy
+49,097
New +$4.12M ﹤0.01% 1376
2021
Q2 		– Sell
-125,727
Closed -$10.7M – 2959
2021
Q1 		$11.2M Buy
125,727
+123,203
+4,881% +$12.2M 0.01% 887
2020
Q4 		$235K Buy
+2,524
New +$201K ﹤0.01% 2739

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Parallax Volatility Advisers's ARKG Position: Q2 2026 in Review

Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 8.3% in Q2 2026, selling an estimated $50.6K and leaving 17,482 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Parallax Volatility Advisers first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.2M in Q1 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Parallax Volatility Advisers held 17,482 shares of ARK Genomic Revolution ETF worth $735K as of Q2 2026.
  • Parallax Volatility Advisers sold 1,589 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $50.6K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1037 holding.
  • Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
  • Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $11.2M in Q1 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.